Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure
- PMID: 18979056
- DOI: 10.1007/s00392-008-0732-z
Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure
Abstract
Background: Reduced glomerular filtration rate (GFR) is strongly associated with reduced survival in patients with chronic heart failure (CHF). Our aim was to determine different pathophysiologic markers that are associated with reduced renal function in CHF.
Methods and results: We studied 86 patients with CHF (58+/-12 years, 78% male). GFR and renal blood flow (RBF) were determined by (125)I-Iothalamate and (131)I-Hippuran clearances. Filtration fraction (FF) was calculated. We determined haemoglobin levels, endothelial function, inflammatory status, plasma renin activity (PRA) and N-terminal pro brain natriuretic peptide (NT-proBNP). Urinary albumin excretion (UAE) was measured in 24 h urine. Mean GFR was 74+/-28 ml/min/1.73 m(2). GFR was strongly related to RBF (r=0.915, P<0.001), FF (r=0.546, P<0.001), but only weakly to endothelial function and PRA. In multivariate analysis, RBF (r=0.938, P < 0.001), FF (r=0.786, P < 0.001) and haemoglobin levels (r= -0.520, P<0.001) were independently associated with GFR. UAE was mainly dependent on RBF (r= -0.401, P < 0.001) and increased exponentially with decreasing RBF. RBF was mainly associated with NT-proBNP (r= -0.561, P<0.001) and PRA (r= -0.422, P<0.001).
Conclusion: Reduced GFR is mainly dependent of decreased RBF in patients with CHF. Endothelial function and neurohormonal activation showed only mild associations with GFR. NT-proBNP showed a strong relationship with RBF, and may be used as a marker of reduced renal perfusion.
Similar articles
-
Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).Am Heart J. 2015 May;169(5):693-701.e3. doi: 10.1016/j.ahj.2014.12.016. Epub 2015 Jan 7. Am Heart J. 2015. PMID: 25965717 Clinical Trial.
-
Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.Circulation. 2009 Jul 7;120(1):35-41. doi: 10.1161/CIRCULATIONAHA.108.824581. Epub 2009 Jun 22. Circulation. 2009. PMID: 19546389
-
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. doi: 10.1016/j.jacc.2005.08.051. Epub 2005 Dec 9. J Am Coll Cardiol. 2006. PMID: 16386670
-
Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure.Cardiology. 1989;76 Suppl 2:50-5. doi: 10.1159/000174559. Cardiology. 1989. PMID: 2670221 Review.
-
Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure.Heart Fail Rev. 2012 Mar;17(2):161-75. doi: 10.1007/s10741-011-9246-2. Heart Fail Rev. 2012. PMID: 21553212 Review.
Cited by
-
Biomarkers: optimizing treatment guidance in heart failure.Clin Res Cardiol. 2011 Nov;100(11):973-81. doi: 10.1007/s00392-011-0341-0. Epub 2011 Jul 16. Clin Res Cardiol. 2011. PMID: 21779815 Review.
-
Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?Clin Res Cardiol. 2011 Dec;100(12):1059-67. doi: 10.1007/s00392-011-0340-1. Epub 2011 Jul 16. Clin Res Cardiol. 2011. PMID: 21779816
-
Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes.Front Cardiovasc Med. 2021 Jan 28;7:630917. doi: 10.3389/fcvm.2020.630917. eCollection 2020. Front Cardiovasc Med. 2021. PMID: 33585587 Free PMC article. Review.
-
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.Clin Res Cardiol. 2010 May;99(5):323-8. doi: 10.1007/s00392-010-0125-y. Epub 2010 Feb 4. Clin Res Cardiol. 2010. PMID: 20130888 Free PMC article.
-
Current and novel renal biomarkers in heart failure.Heart Fail Rev. 2012 Mar;17(2):241-50. doi: 10.1007/s10741-011-9254-2. Heart Fail Rev. 2012. PMID: 21604178 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials